N-Methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood–brain barrier in vivo
- 1 January 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in NeuroReport
- Vol. 13 (1), 25-28
- https://doi.org/10.1097/00001756-200201210-00010
Abstract
In earlier studies the dihydroxylated tetrahydroisoquinoline derivatives salsolinol and 2(N)-methyl-norsalsolinol (NMNorsal), a 2(N)-analogue of salsolinol, were identified as putative endogenous neurotoxins in patients with Parkinson's disease. Since a prominent blood–brain barrier (BBB) was described to exist for salsolinol, in the present study microdialysis experiments were performed to investigate the penetration of NMNorsal through the BBB into the caudate nucleus of the rat brain. After i.p. administration of NMNorsal (20 mg/kg), it could be detected in the dialysate of the caudate nucleus with a mean maximum after 40 min. There was no alteration in extracellular dopamine or 3,4-dihydroxyphenylacetic acid levels. Addition of the monoamine oxidase inhibitor pargyline (10 μM) to the perfusate did not modify NMNorsal levels in the caudate nucleus. To corroborate the microdialysis results, homogenates of the contralateral caudate nucleus were prepared and NMNorsal could also be detected. These findings indicate that NMNorsal is indeed able to pass through the blood–brain barrier of the rat brain.Keywords
This publication has 16 references indexed in Scilit:
- Selegiline induces dopamine release through ATP-sensitive potassium channels in the rat caudate-putamen in vitro.Neurochemistry International, 1997
- Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's diseaseJournal of the Neurological Sciences, 1995
- Inhibition of type a monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ionsNeurochemistry International, 1994
- Presence of methyl-6, 7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSFLife Sciences, 1992
- N‐Methylation of Dopamine‐Derived 6,7‐Dihydroxy‐1,2,3,4‐Tetrahydroisoquinoline, (R)‐Salsolinol, in Rat Brains: In Vivo Microdialysis StudyJournal of Neurochemistry, 1992
- Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brainsBiochemical and Biophysical Research Communications, 1991
- A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ionBiochemical and Biophysical Research Communications, 1989
- Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: Compounds related to Parkinson's diseaseLife Sciences, 1988
- Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis StudyJournal of Neurochemistry, 1988
- Rat brain salsolinol and blood-brain barrierBrain Research, 1981